Endpoints News ١٤ أبريل ٢٠٢٦ Parker Institute doubles down on cancer vaccines as part of ongoing reboot
Endpoints News ١٤ أبريل ٢٠٢٦ FDA approves Travere's Filspari as first drug for the kidney disease FSGS
Endpoints News ١٣ أبريل ٢٠٢٦ White House policies are ‘incredibly worrisome’ for small biotechs, Rhythm CEO says
Endpoints News ١٣ أبريل ٢٠٢٦ Neomorph raises $100M for molecular glues; Spyre's ulcerative colitis data
Endpoints News ١٣ أبريل ٢٠٢٦ Revolution Medicines' pancreatic cancer drug doubles survival time in Phase 3
Endpoints News ١٣ أبريل ٢٠٢٦ Ideaya’s uveal melanoma drug exceeds success benchmark in late-stage trial
Endpoints News ١١ أبريل ٢٠٢٦ More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more
Endpoints News ١٠ أبريل ٢٠٢٦ Plan for remade ACIP panel adds focus on vaccine safety, matching Kennedy’s push
Endpoints News ١٠ أبريل ٢٠٢٦ FDA rejects Replimune cancer therapy, saying company didn't resolve trial doubts